» Articles » PMID: 3170432

Relationship Between Maximal Expiratory Flows and Lung Volumes in Growing Humans

Overview
Date 1988 Aug 1
PMID 3170432
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

We examined airway vs. lung parenchymal growth, as inferred from maximal expiratory flows (MEF) and lung volumes (V), respectively, to determine whether the interindividual variability of airway size (inferred from MEF) changes during lung growth and whether a young child with large (or small) airways for his parenchymal size (inferred from V) maintains relatively large (or small) airways for his lung size as he grows to adulthood. Serial measurements of MEF and V were obtained from a cohort of healthy 6- to 27-yr-old males (n = 26) and females (n = 21) over a period of 18 yr. Data were analyzed using logarithmic transformation of the power law equation, MEF = aVb, to fit a regression line to each subject's data points. These growth trajectories were satisfactorily modeled as parallel lines with 20-30% variability of their y-intercepts, indicating that substantial intersubject variability of MEF relative to V is present in early childhood and remains constant during growth. The results further indicate that MEF does track V during lung growth. We conclude that dysanapsis originates in early childhood.

Citing Articles

Unraveling Dysanapsis: Genetic Insights into Airway Lung Mismatch and COPD.

Yang A, Bon J Am J Respir Crit Care Med. 2024; 210(12):1391-1392.

PMID: 39078250 PMC: 11716036. DOI: 10.1164/rccm.202406-1256ED.


Dysanapsis as a Determinant of Lung Function in Development and Disease.

McGinn E, Mandell E, Smith B, Duke J, Bush A, Abman S Am J Respir Crit Care Med. 2023; 208(9):956-963.

PMID: 37677135 PMC: 10870865. DOI: 10.1164/rccm.202306-1120PP.


Gold 2023: Highlights for primary care.

Agusti A, Siso-Almirall A, Roman M, Vogelmeier C NPJ Prim Care Respir Med. 2023; 33(1):28.

PMID: 37524724 PMC: 10390461. DOI: 10.1038/s41533-023-00349-4.


Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

Agusti A, Celli B, Criner G, Halpin D, Anzueto A, Barnes P Eur Respir J. 2023; 61(4).

PMID: 36858443 PMC: 10066569. DOI: 10.1183/13993003.00239-2023.


Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

Agusti A, Celli B, Criner G, Halpin D, Anzueto A, Barnes P Am J Respir Crit Care Med. 2023; 207(7):819-837.

PMID: 36856433 PMC: 10111975. DOI: 10.1164/rccm.202301-0106PP.